This Article Full Text Full Text (PDF) All Versions of this Article: j.jacc.2007.03.033v1 50/2/159    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Meuwese, M. C. Articles by Boekholdt, S. M. Search for Related Content PubMed PubMed Citation Articles by Meuwese, M. C. Articles by Boekholdt, S. M. Related Collections Related Article

CLINICAL RESEARCH: CORONARY ARTERY DISEASE RISK

Serum Myeloperoxidase Levels Are Associated With the Future Risk of Coronary Artery Disease in Apparently Healthy Individuals

The EPIC-Norfolk Prospective Population Study

Marijn C. Meuwese, MD^_*, Erik S.G. Stroes, MD, PhD^_*, Stanley L. Hazen, MD, PhD, Joram N. van Miert, BSc^_*, Jan Albert Kuivenhoven, PhD^_*, Robert G. Schaub, PhD, Nicholas J. Wareham, MB, PhD^||, Robert Luben, BSc^#, John J.P. Kastelein, MD, PhD^_*, Kay-Tee Khaw, MBBChir^# and S. Matthijs Boekholdt, MD, PhD^_*,,_*

^_* Department of Vascular Medicine
Department of Cardiology, Academic Medical Center, Amsterdam, the Netherlands
Department of Cell Biology and the Center for Cardiovascular Diagnostics and Prevention, Cleveland Clinic Foundation, Cleveland, Ohio
Wyeth Research, Cambridge, Massachusetts
^|| MRC Epidemiology Unit, Cambridge, United Kingdom
^# Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Cambridge, United Kingdom

Manuscript received November 27, 2006; revised manuscript received February 27, 2007, accepted March 2, 2007.

^_* Reprint requests and correspondence: Dr. S. Matthijs Boekholdt, Academic Medical Center, Department of Vascular Medicine (F4-159.2), Meibergdreef 9, P.O. Box 22660, 1100 DD Amsterdam, the Netherlands. (Email: s.m.boekholdt{at}amc.uva.nl).

Objectives: We evaluated whether serum myeloperoxidase (MPO) levels are associated with the risk of future development of coronary artery disease (CAD) in apparently healthy individuals.

Background: An enzyme of the innate immune system, MPO exhibits a wide array of proatherogenic effects. These include induction of oxidative damage to low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol and promotion of plaque vulnerability. Recent studies revealed that MPO independently predicts adverse outcomes in patients with chest pain or suspected acute coronary syndrome.

Methods: Myeloperoxidase was measured in baseline samples of a case-control study nested in the prospective EPIC (European Prospective Investigation into Cancer and Nutrition)-Norfolk population study. Case subjects (n = 1,138) were apparently healthy men and women who developed CAD during 8-year follow-up. Control subjects (n = 2,237), matched for age, gender, and enrollment time, remained free of CAD.

Results: The MPO levels were significantly higher in case subjects than in control subjects and correlated with C-reactive protein (CRP) ( = 0.25; p < 0.001) and white blood cell count ( = 0.33; p < 0.001). Risk of future CAD increased in consecutive quartiles of MPO concentration, with an odds ratio (OR) of 1.49 in the top versus bottom quartile (95% confidence interval [CI] 1.20 to 1.84; p < 0.001). After adjustment for traditional risk factors, the OR in the top quartile remained significant at 1.36 (95% CI 1.07 to 1.73). Elevated MPO levels (>728 pmol/l) similarly predicted increased risk of future CAD among participants with either LDL-cholesterol <130 mg/dl, HDL-cholesterol >50 mg/dl, or CRP <2.0 mg/l (OR 1.52 [95% CI 1.21 to 1.91], 1.59 [95% CI 1.24 to 2.05], and 1.42 [95% CI 1.14 to 1.77)], respectively).

Conclusion: Elevated MPO levels predict future risk of CAD in apparently healthy individuals. This study suggests that inflammatory activation precedes the onset of overt CAD by many years.

Abbreviations and Acronyms   ACS = acute coronary syndrome   BMI = body mass index   CAD = coronary artery disease   CRP = C-reactive protein   CVD = cardiovascular disease   HDL = high-density lipoprotein   LDL = low-density lipoprotein   MPO = myeloperoxidase   OR = odds ratio

Related Article

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2007 50: A32. [Full Text] [PDF]

This article has been cited by other articles:

				M. Madjid and J. T. Willerson Inflammatory markers in coronary heart disease Br. Med. Bull., December 1, 2011; 100(1): 23 - 38. [Abstract] [Full Text] [PDF]

				S. J. Nicholls, W. H. Wilson Tang, D. Brennan, M.-L. Brennan, S. Mann, S. E. Nissen, and S. L. Hazen Risk Prediction with Serial Myeloperoxidase Monitoring in Patients with Acute Chest Pain Clin. Chem., December 1, 2011; 57(12): 1762 - 1770. [Abstract] [Full Text] [PDF]

				A. Ravandi, S. M. Boekholdt, Z. Mallat, P. J. Talmud, J. J. P. Kastelein, N. J. Wareham, E. R. Miller, J. Benessiano, A. Tedgui, J. L. Witztum, et al. Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study J. Lipid Res., October 1, 2011; 52(10): 1829 - 1836. [Abstract] [Full Text] [PDF]

				H. J. Fullerton, M. S. V. Elkind, A. J. Barkovich, C. Glaser, D. Glidden, N. K. Hills, C. Leiva-Salinas, M. Wintermark, and G. A. deVeber The Vascular Effects of Infection in Pediatric Stroke (VIPS) Study J Child Neurol, September 1, 2011; 26(9): 1101 - 1110. [Abstract] [PDF]

				T. K. Rudolph, S. Wipper, B. Reiter, V. Rudolph, A. Coym, C. Detter, D. Lau, A. Klinke, K. Friedrichs, T. Rau, et al. Myeloperoxidase deficiency preserves vasomotor function in humans Eur. Heart J., June 30, 2011; (2011) ehr193v1. [Abstract] [Full Text] [PDF]

				F. C. Meotti, G. N. L. Jameson, R. Turner, D. T. Harwood, S. Stockwell, M. D. Rees, S. R. Thomas, and A. J. Kettle Urate as a Physiological Substrate for Myeloperoxidase: IMPLICATIONS FOR HYPERURICEMIA AND INFLAMMATION J. Biol. Chem., April 15, 2011; 286(15): 12901 - 12911. [Abstract] [Full Text] [PDF]

				F. S. Apple, S. W. Smith, L. A. Pearce, K. M. Schulz, R. Ler, and M. M. Murakami Myeloperoxidase Improves Risk Stratification in Patients with Ischemia and Normal Cardiac Troponin I Concentrations Clin. Chem., April 1, 2011; 57(4): 603 - 608. [Abstract] [Full Text] [PDF]

				J. S. Rana, B. J. Arsenault, J.-P. Despres, M. Cote, P. J. Talmud, E. Ninio, J. Wouter Jukema, N. J. Wareham, J. J. P. Kastelein, K.-T. Khaw, et al. Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women Eur. Heart J., February 1, 2011; 32(3): 336 - 344. [Abstract] [Full Text] [PDF]

				W. H. W. Tang, Y. Wu, S. J. Nicholls, and S. L. Hazen Plasma Myeloperoxidase Predicts Incident Cardiovascular Risks in Stable Patients Undergoing Medical Management for Coronary Artery Disease Clin. Chem., January 1, 2011; 57(1): 33 - 39. [Abstract] [Full Text] [PDF]

				S. Tsimikas, Z. Mallat, P. J. Talmud, J. J. P. Kastelein, N. J. Wareham, M. S. Sandhu, E. R. Miller, J. Benessiano, A. Tedgui, J. L. Witztum, et al. Oxidation-Specific Biomarkers, Lipoprotein(a), and Risk of Fatal and Nonfatal Coronary Events J. Am. Coll. Cardiol., September 14, 2010; 56(12): 946 - 955. [Abstract] [Full Text] [PDF]

				P. Gururajan, P. Gurumurthy, P. Nayar, S. Babu, A. Sarasabharati, D. Victor, and K. M. Cherian Serum myeloperoxidase: a novel biomarker for evaluation of patients with acute coronary syndrome Heart Asia, July 5, 2010; 1(1): 41 - 46. [Abstract] [Full Text] [PDF]

				V. Rudolph and S. Baldus Myeloperoxidase for Guiding Therapy for Acute Cardiac Decompensation? It's Heart to Tell Clin. Chem., June 1, 2010; 56(6): 881 - 882. [Full Text] [PDF]

				L. P. Van der Zwan, P. G. Scheffer, J. M. Dekker, C. D. A. Stehouwer, R. J. Heine, and T. Teerlink Hyperglycemia and Oxidative Stress Strengthen the Association Between Myeloperoxidase and Blood Pressure Hypertension, June 1, 2010; 55(6): 1366 - 1372. [Abstract] [Full Text] [PDF]

				S. Giovannini, G. Onder, C. Leeuwenburgh, C. Carter, E. Marzetti, A. Russo, E. Capoluongo, M. Pahor, R. Bernabei, and F. Landi Myeloperoxidase Levels and Mortality in Frail Community-Living Elderly Individuals J Gerontol A Biol Sci Med Sci, April 1, 2010; 65A(4): 369 - 376. [Abstract] [Full Text] [PDF]

				C. L. Heslop, J. J. Frohlich, and J. S. Hill Myeloperoxidase and C-Reactive Protein Have Combined Utility for Long-Term Prediction of Cardiovascular Mortality After Coronary Angiography J. Am. Coll. Cardiol., March 16, 2010; 55(11): 1102 - 1109. [Abstract] [Full Text] [PDF]

				I. Tzoulaki, G. Liberopoulos, and J. P. A. Ioannidis Assessment of Claims of Improved Prediction Beyond the Framingham Risk Score JAMA, December 2, 2009; 302(21): 2345 - 2352. [Abstract] [Full Text] [PDF]

				A. Undurti, Y. Huang, J. A. Lupica, J. D. Smith, J. A. DiDonato, and S. L. Hazen Modification of High Density Lipoprotein by Myeloperoxidase Generates a Pro-inflammatory Particle J. Biol. Chem., November 6, 2009; 284(45): 30825 - 30835. [Abstract] [Full Text] [PDF]

				H. Zhang, D.-x. Wang, F. Xiao, J. Li, Z.-s. He, and Y.-l. Wan The impact of previous or concomitant myocardium revascularization on the outcomes of patients undergoing major non-cardiac surgery Interact CardioVasc Thorac Surg, November 1, 2009; 9(5): 788 - 792. [Abstract] [Full Text] [PDF]

				J S Rana, M Cote, J-P Despres, M S Sandhu, P J Talmud, E Ninio, N J Wareham, J J P Kastelein, A H Zwinderman, K-T Khaw, et al. Inflammatory biomarkers and the prediction of coronary events among people at intermediate risk: the EPIC-Norfolk prospective population study Heart, October 15, 2009; 95(20): 1682 - 1687. [Abstract] [Full Text] [PDF]

				N. D. Wong, H. Gransar, J. Narula, L. Shaw, J. H. Moon, R. Miranda-Peats, A. Rozanski, S. W. Hayes, L. E.J. Thomson, J. D. Friedman, et al. Myeloperoxidase, Subclinical Atherosclerosis, and Cardiovascular Disease Events J. Am. Coll. Cardiol. Img., September 1, 2009; 2(9): 1093 - 1099. [Abstract] [Full Text] [PDF]

				W.H. W. Tang Enhancing the Prognostic Value of Cardiac Imaging With Multimodal Risk Assessment J. Am. Coll. Cardiol. Img., September 1, 2009; 2(9): 1100 - 1102. [Full Text] [PDF]

				J. A. Ronald, J. W. Chen, Y. Chen, A. M. Hamilton, E. Rodriguez, F. Reynolds, R. A. Hegele, K. A. Rogers, M. Querol, A. Bogdanov, et al. Enzyme-Sensitive Magnetic Resonance Imaging Targeting Myeloperoxidase Identifies Active Inflammation in Experimental Rabbit Atherosclerotic Plaques Circulation, August 18, 2009; 120(7): 592 - 599. [Abstract] [Full Text] [PDF]

				Z. Ali, P. Sarcia, T. H Mosley, V. Kondragunta, and I. J Kullo Association of serum myeloperoxidase with the ankle-brachial index and peripheral arterial disease Vascular Medicine, August 1, 2009; 14(3): 215 - 220. [Abstract] [PDF]

				R. K. Schindhelm, L. P. van der Zwan, T. Teerlink, and P. G. Scheffer Myeloperoxidase: A Useful Biomarker for Cardiovascular Disease Risk Stratification? Clin. Chem., August 1, 2009; 55(8): 1462 - 1470. [Abstract] [Full Text] [PDF]

				R. Talati, K. M Reinhart, C M. White, O. J Phung, A. Sedrakyan, J. Kluger, and C. I Coleman Outcomes of Perioperative {beta}-Blockade in Patients Undergoing Noncardiac Surgery: A Meta-Analysis Ann. Pharmacother., July 1, 2009; 43(7): 1181 - 1188. [Abstract] [Full Text] [PDF]

				S. J. Nicholls and S. L. Hazen Myeloperoxidase, modified lipoproteins, and atherogenesis J. Lipid Res., April 1, 2009; 50(Supplement): S346 - S351. [Abstract] [Full Text] [PDF]

				K. El Harchaoui, B. J. Arsenault, R. Franssen, J.-P. Despres, G. K. Hovingh, E. S.G. Stroes, J. D. Otvos, N. J. Wareham, J. J.P. Kastelein, K.-T. Khaw, et al. High-Density Lipoprotein Particle Size and Concentration and Coronary Risk Ann Intern Med, January 20, 2009; 150(2): 84 - 93. [Abstract] [Full Text] [PDF]

				T. K. Rudolph, V. Rudolph, and S. Baldus Contribution of Myeloperoxidase to Smoking-dependent Vascular Inflammation Proceedings of the ATS, December 1, 2008; 5(8): 820 - 823. [Abstract] [Full Text] [PDF]

				N. Johnston, H. Dargie, and A. Jardine Diagnosis and treatment of coronary artery disease in patients with chronic kidney disease Heart, August 1, 2008; 94(8): 1080 - 1088. [Full Text] [PDF]

				M. Weber and C. Hamm Novel biomarkers--the long march from bench to bedside Eur. Heart J., May 1, 2008; 29(9): 1079 - 1081. [Full Text] [PDF]

				H. L. Gornik Peripheral arterial disease enters the biomarker era. Does risk stratification tell us something that we don't already know? Eur. Heart J., January 2, 2008; 29(2): 150 - 152. [Full Text] [PDF]